We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current RX market cap is 120.63M. The company's latest EPS is CAD 0.6328 and P/E is 16.59.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 22.33M | 28.62M | 27.93M | 31.59M | 35.03M |
| Operating Income | 5.29M | 8.61M | 7.26M | 8.06M | 8.63M |
| Net Income | 3.8M | 6.28M | 5.46M | 6.46M | 7.27M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 33.57M | 37.17M | 40.49M | 41.53M | 41.36M |
| Total Liabilities | 6.78M | 5.61M | 7.12M | 6.77M | 6.36M |
| Total Equity | 26.8M | 31.56M | 33.36M | 34.76M | 35M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | 6.89M | 4.68M | 4.95M | 5.05M | 8.66M |
| Investing | 3.39M | -4.84M | -10.79M | 884k | 3.29M |
| Financing | -3.37M | -2.08M | -4.37M | -5.79M | -7.83M |
| Market Cap | 120.63M |
| Price to Earnings Ratio | 16.59 |
| Price to Sales Ratio | 3.44 |
| Price to Cash Ratio | 9.96 |
| Price to Book Ratio | 3.45 |
| Dividend Yield | - |
| Shares Outstanding | 11.49M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.2 (1.87%) |
| Company Name | Biosyent Inc |
| Address |
2476 argentia road mississauga, ontario L5N 6M1 |
| Website | https://www.biosyent.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
